Orexo Ab Stock Today
| ORXOF Stock | USD 1.08 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 44
|
Orexo AB is trading at 1.08 as of the 22nd of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.08. Orexo AB has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Orexo AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Orexo AB was incorporated in 1994 and is headquartered in Uppsala, Sweden. Orexo Ab is traded on OTC Exchange in the United States.. The company has 34.35 M outstanding shares. More on Orexo AB
Moving together with Orexo OTC Stock
| 0.75 | MKKGY | Merck KGaA ADR | PairCorr |
| 0.77 | MKGAF | MERCK Kommanditgesells | PairCorr |
| 0.76 | HLN | Haleon plc | PairCorr |
| 0.83 | TAK | Takeda Pharmaceutical | PairCorr |
Moving against Orexo OTC Stock
| 0.74 | WMT | Walmart Aggressive Push | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Orexo OTC Stock Highlights
| Pres CEO | Nikolaj Sorensen |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Orexo AB [ORXOF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 58.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orexo AB's market, we take the total number of its shares issued and multiply it by Orexo AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Orexo AB classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 34.35 M outstanding shares.
Orexo AB has accumulated about 45.61 M in cash with (229 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Orexo AB Probability Of Bankruptcy
Ownership AllocationOrexo AB owns a total of 34.35 Million outstanding shares. 30% of Orexo AB outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Orexo Ownership Details
Orexo AB Risk Profiles
| Mean Deviation | 0.8356 | |||
| Standard Deviation | 3.45 | |||
| Variance | 11.88 | |||
| Risk Adjusted Performance | (0.09) |
Orexo Stock Against Markets
Picking the right benchmark for Orexo AB otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Orexo AB otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Orexo AB is critical whether you are bullish or bearish towards Orexo AB at a given time. Please also check how Orexo AB's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Orexo AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Orexo AB Corporate Management
Elected by the shareholders, the Orexo AB's board of directors comprises two types of representatives: Orexo AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orexo. The board's role is to monitor Orexo AB's management team and ensure that shareholders' interests are well served. Orexo AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orexo AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fredrik Jarrsten | Ex CFO | Profile | |
| MD MBA | Chief Officer | Profile | |
| Cecilia Coupland | VP Operations | Profile | |
| Lena Wange | Investor Relations & Communications Manager | Profile | |
| Jesper Lind | Advisor | Profile | |
| Dennis Urbaniak | Ex Therapeutics | Profile |
Other Information on Investing in Orexo OTC Stock
Orexo AB financial ratios help investors to determine whether Orexo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Orexo with respect to the benefits of owning Orexo AB security.